Megyn Kelly & FDA Chief on COVID Accountability
In a striking interview, Megyn Kelly pressed FDA Commissioner Dr. Marty Makary on a critical question: Was there a deliberate cover-up of COVID vaccine risks by agencies like the FDA and NIH?
Kelly suggested officials may have "scrubbed the record" before departing, but questioned if any evidence of misconduct remained.
Dr. Makary’s response was a stunning admission. He confirmed that officials were, in fact, "sitting on data" concerning myocarditis in young, healthy individuals—and failed to act in a timely manner.
The FDA's response, he stated, was to issue a strong warning and change its policy. Notably, the agency will no longer offer a "rubber stamp" for annual vaccines for healthy children without clinical trial data—a direct result of the loss of trust, evidenced by 85% of healthcare workers rejecting the last booster.
While Dr. Makary pivoted to a forward-looking stance, the takeaway is clear: A top official has publicly acknowledged that federal health agencies withheld vital safety information from the public.